http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013039380-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8ce063b4beb131bf7173b4c1cffb339b http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8735ee8161df1d8ed1cf1943c853e678 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_adf8457488361b2ebc212a301c439c4f |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-734 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-721 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-36 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-19 |
| filingDate | 2012-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_17c12ca7c47aa8c51a335eb6c21fc29d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_45f7f0e253c3b49754e5101a6c34e970 |
| publicationDate | 2013-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2013039380-A1 |
| titleOfInvention | Sterile alginate-based aqueous composition for medical use and process for the preparation thereof |
| abstract | The present invention relates to ready-to-use sterile, alginate-based, aqueous compositions for medical use. More particularly, the invention relates to an aqueous composition for medical use that has been sterilized by heat sterilization and having a viscosity at 25 °C of at least 300 cP (Helipath® T F spindle, 100 rpm at 25 °C), said composition having a pH in the range of 6.5-7.5; containing 0.5-10 wt.% of an alginate salt; and further containing 10-500 mM of one or more dissolved C 8 -C 12 fatty acid salts. The alginate-based composition of the present invention has excellent storage stability and is easy to manufacture. The alginate-based aqueous compositions of the present invention can advantageously be used, for instance, to prevent adhesions between a healing trauma site and adjacent surrounding tissue. These compositions can further be used in implants or in pharmaceutical preparations for oral administration. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2537803-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2537803-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2618435-C1 |
| priorityDate | 2011-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 43.